JP2020510044A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510044A5
JP2020510044A5 JP2019549454A JP2019549454A JP2020510044A5 JP 2020510044 A5 JP2020510044 A5 JP 2020510044A5 JP 2019549454 A JP2019549454 A JP 2019549454A JP 2019549454 A JP2019549454 A JP 2019549454A JP 2020510044 A5 JP2020510044 A5 JP 2020510044A5
Authority
JP
Japan
Prior art keywords
alkyl
carbocyclyl
compound
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510044A (ja
JP7323179B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/021848 external-priority patent/WO2018165611A1/en
Publication of JP2020510044A publication Critical patent/JP2020510044A/ja
Publication of JP2020510044A5 publication Critical patent/JP2020510044A5/ja
Application granted granted Critical
Publication of JP7323179B2 publication Critical patent/JP7323179B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549454A 2017-03-10 2018-03-09 排出ポンプ阻害剤としてのインドール誘導体 Active JP7323179B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762469987P 2017-03-10 2017-03-10
US62/469,987 2017-03-10
US201762523154P 2017-06-21 2017-06-21
US62/523,154 2017-06-21
PCT/US2018/021848 WO2018165611A1 (en) 2017-03-10 2018-03-09 Indole derivatives as efflux pump inhibitors

Publications (3)

Publication Number Publication Date
JP2020510044A JP2020510044A (ja) 2020-04-02
JP2020510044A5 true JP2020510044A5 (cg-RX-API-DMAC7.html) 2021-04-15
JP7323179B2 JP7323179B2 (ja) 2023-08-08

Family

ID=62044950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549454A Active JP7323179B2 (ja) 2017-03-10 2018-03-09 排出ポンプ阻害剤としてのインドール誘導体

Country Status (12)

Country Link
US (1) US11993571B2 (cg-RX-API-DMAC7.html)
EP (1) EP3592736A1 (cg-RX-API-DMAC7.html)
JP (1) JP7323179B2 (cg-RX-API-DMAC7.html)
KR (1) KR102697360B1 (cg-RX-API-DMAC7.html)
CN (1) CN110770224B (cg-RX-API-DMAC7.html)
AU (1) AU2018231120B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019018691A2 (cg-RX-API-DMAC7.html)
CA (1) CA3061238A1 (cg-RX-API-DMAC7.html)
IL (1) IL269210B2 (cg-RX-API-DMAC7.html)
MX (1) MX2019010717A (cg-RX-API-DMAC7.html)
SG (1) SG11201908351TA (cg-RX-API-DMAC7.html)
WO (1) WO2018165611A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017147335A1 (en) 2016-02-24 2017-08-31 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
WO2017147333A1 (en) 2016-02-24 2017-08-31 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
AU2018231120B2 (en) 2017-03-10 2022-06-23 Rutgers, The State University Of New Jersey Indole derivatives as efflux pump inhibitors
WO2018165614A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
WO2018165612A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP3630109A4 (en) 2017-05-26 2021-03-17 Rutgers, the State University of New Jersey BACTERIAL EFFLUX PUMP INHIBITORS
US11458121B2 (en) 2017-06-26 2022-10-04 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
WO2019099402A1 (en) * 2017-11-14 2019-05-23 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
KR102704123B1 (ko) 2019-11-01 2024-09-06 에스엘 주식회사 차량용 램프
WO2025043115A1 (en) 2023-08-23 2025-02-27 Taxis Pharmaceuticals, Inc. Bacterial efflux pump inhibitors
WO2025049604A1 (en) * 2023-08-29 2025-03-06 Maze Therapeutics, Inc. Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3465080A (en) * 1968-10-07 1969-09-02 American Cyanamid Co Therapeutic compositions containing morpholinoalkylene - indoles and methods of administering such in the treatment of depression
US3978224A (en) 1975-07-01 1976-08-31 Schering Corporation Antimicrobial halo-substituted-2-cyanoethylaminoalkyl-3-phenyl-indoles
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO1992004017A1 (en) 1990-09-10 1992-03-19 The Upjohn Company Cis-n-(2-aminocyclohexyl)benzamide and their enantiomers as anticonvulsants
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
US5663152A (en) 1995-01-19 1997-09-02 Asahi Kasei Kogyo Kabushiki Kaisha Potentiators for aminoglycosides
US6506339B1 (en) * 1997-02-10 2003-01-14 Biomedical Design, Inc. Method of sterilization
WO1999037667A1 (en) * 1998-01-23 1999-07-29 Microcide Pharmaceuticals, Inc. Efflux pump inhibitors
US6204279B1 (en) 1998-06-03 2001-03-20 Microcide Pharmaceuticals, Inc. Peptidomimetic efflux pump inhibitors
US6326391B1 (en) 1998-12-04 2001-12-04 Influx, Inc. Inhibitors of multidrug transporters
AU7866300A (en) 1999-10-08 2001-04-23 Smithkline Beecham Corporation Fab i inhibitors
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6555569B2 (en) 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
WO2011101710A1 (en) 2010-02-16 2011-08-25 Wockhardt Research Centre Efflux pump inhibitors
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
HUP0103986A2 (hu) * 2001-09-28 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Új karbonsavamid szerkezetet tartalmazó piperidinil vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
WO2004062674A2 (en) 2003-01-07 2004-07-29 Paratek Pharmaceuticals, Inc. Substituted polyamines as inhibitors of bacterial efflux pumps
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
US7994225B2 (en) 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
AU2005245962A1 (en) 2004-05-21 2005-12-01 Mpex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors and methods of treating bacterial infections
WO2006058088A2 (en) 2004-11-23 2006-06-01 Ptc Therapeutics, Inc. Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
US7855228B2 (en) 2005-02-10 2010-12-21 The Board Of Trustees Of The Leland Stamford Junior University Antibiotics targeting MreB
US7807704B2 (en) 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
CA2927045A1 (en) 2006-10-03 2008-04-10 Muthiah Manoharan Lipid containing formulations
AR070398A1 (es) * 2008-02-22 2010-03-31 Gruenenthal Chemie Derivados sustituidos de indol
WO2009110002A1 (en) 2008-03-05 2009-09-11 Council Of Scientific & Industrial Research Novel efflux pump inhibitors
WO2010033168A2 (en) 2008-09-18 2010-03-25 Renovis, Inc. Amide compounds, compositions and uses thereof
EP2414368B1 (en) 2009-04-03 2013-11-27 Achillion Pharmaceuticals, Inc. Hydroxythienoquinolones and related compounds as anti-infective agents
EP2394653A1 (en) * 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
FR2969150B1 (fr) * 2010-12-20 2013-07-26 Centre Nat Rech Scient Nouvelles molecules indoliques demontrant des activites antibacteriennes dans une variete de bacteries a gram-negatif et positif dont des bacteries multidrogues-resistantes
JP6223452B2 (ja) 2012-09-07 2017-11-01 ノバルティス アーゲー インドールカルボキサミド誘導体およびその使用
WO2014078294A1 (en) * 2012-11-13 2014-05-22 Memorial Sloan-Kettering Cancer Center Indole compounds and their use as antimicrobials
WO2015164482A1 (en) 2014-04-22 2015-10-29 The Johns Hopkins University Inhibitors of drug-resistant mycobacterium tuberculosis
CA2960275A1 (en) * 2014-09-10 2016-03-17 Epizyme, Inc. Smyd inhibitors
US9926261B2 (en) 2015-03-10 2018-03-27 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US9950993B2 (en) 2015-03-13 2018-04-24 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP3307725A1 (en) 2015-06-11 2018-04-18 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
EP3331530A4 (en) * 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
WO2017147335A1 (en) 2016-02-24 2017-08-31 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
WO2017147333A1 (en) 2016-02-24 2017-08-31 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
ES2968227T3 (es) * 2016-12-23 2024-05-08 Aquinnah Pharmaceuticals Inc Compuestos, composiciones y procedimientos de uso
AU2018231120B2 (en) 2017-03-10 2022-06-23 Rutgers, The State University Of New Jersey Indole derivatives as efflux pump inhibitors
WO2018165614A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
WO2018165612A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP3630109A4 (en) 2017-05-26 2021-03-17 Rutgers, the State University of New Jersey BACTERIAL EFFLUX PUMP INHIBITORS
US11458121B2 (en) * 2017-06-26 2022-10-04 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
US20190031624A1 (en) 2017-07-28 2019-01-31 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
WO2019099402A1 (en) * 2017-11-14 2019-05-23 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection

Similar Documents

Publication Publication Date Title
JP2020510044A5 (cg-RX-API-DMAC7.html)
JP2020527597A5 (cg-RX-API-DMAC7.html)
Kiyotoki et al. Efficacy of vonoprazan for Helicobacter pylori eradication
CA2504448A1 (en) Transcription factor modulating compounds and methods of use thereof
FI3651766T3 (fi) 4-(4-(4-(((2-(2,6-dioksopiperidin-3-yyli)-l-oksoisoindolin-4-yyli)oksi)metyyli)bentsyyli)piperatsin-1-yyli)-3-fluoribentsonitriili antiproliferatiivisena yhdisteenä
JP2017517567A5 (cg-RX-API-DMAC7.html)
JP7323179B2 (ja) 排出ポンプ阻害剤としてのインドール誘導体
JP5852007B2 (ja) 抗微生物剤の増進剤としてのカルコン類
JP2005530784A5 (cg-RX-API-DMAC7.html)
RU2013104951A (ru) Циклические бороновые кислотно-эфирные производные и их использование в терапии
SI2344129T1 (en) AEROSOL FLUOROKINOLONAL FORMULATIONS FOR IMPROVED PHARMACOKINETICS
JP2009541332A5 (cg-RX-API-DMAC7.html)
RU2018122505A (ru) Макроциклические антибиотики широкого спектра действия
JP2016517851A5 (cg-RX-API-DMAC7.html)
RU2016107436A (ru) Линейные пептидные антибиотики
JP2016528257A5 (cg-RX-API-DMAC7.html)
US20190031624A1 (en) Therapeutic compounds and methods to treat infection
JP2016501864A5 (cg-RX-API-DMAC7.html)
FI3986419T3 (fi) Boorihappojohdannaisia ja niiden terapeuttisia käyttöjä
WO2004062674A2 (en) Substituted polyamines as inhibitors of bacterial efflux pumps
RU2018122498A (ru) Макроциклические антибиотики широкого спектра действия
MX2022009197A (es) Metodos de tratamiento para deficiencia de alfa-1 antitripsina.
MX2022011431A (es) Compuesto de oxazolidinona y metodos de uso de este como agente antibacteriano.
CA2768582A1 (en) Spectinamides as anti-tuberculosis agents
JP2020507564A5 (cg-RX-API-DMAC7.html)